brazilin has been researched along with Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ali Hussaini, SM; Babu, BN; Kamal, A; Krishna, NH; Saraswati, AP | 1 |
| Bello-Martínez, J; Cayetano-Salazar, L; Herrera-Zúñiga, LD; Mendoza-Catalán, MA; Nava-Tapia, DA; Navarro-Tito, N | 1 |
2 review(s) available for brazilin and Neoplasms
| Article | Year |
|---|---|
Glycogen synthase kinase-3 and its inhibitors: Potential target for various therapeutic conditions.
Topics: Alzheimer Disease; Antineoplastic Agents; Diabetes Mellitus; Glycogen Synthase Kinase 3; Humans; Hypoglycemic Agents; Neoplasms; Neurodegenerative Diseases; Neuroprotective Agents; Protein Kinase Inhibitors | 2018 |
Brazilin: Biological activities and therapeutic potential in chronic degenerative diseases and cancer.
Topics: Animals; Antineoplastic Agents, Phytogenic; Benzopyrans; Chronic Disease; Ethnopharmacology; Fabaceae; Humans; Medicine, Traditional; Neoplasms; Phytotherapy | 2022 |